Cost-effectiveness analysis of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy in Mexico

被引：0
|
作者：
Arreola-Ornelas, H. [1 ]
Dorantes-Aguilar, J. [1 ]
Garcia-Mollinedo, M. D. L. [2 ]
Rosado-Buzzo, A. A. [2 ]
Mould-Quevedo, J. [3 ]
Davila-Loaiza, G. [3 ]
机构：
[1] Fdn Mexicana Salud, Mexico City, DF, Mexico
[2] Links & Links SA CV, Mexico City, DF, Mexico
[3] Pfizer Mexico, Mexico City, DF, Mexico
来源：
VALUE IN HEALTH | 2008年 / 11卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)70069-3
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A17 / A18
页数：2
相关论文
共 50 条
  • [1] Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective
    Tarride, Jean-Eric
    Gordon, Allan
    Vera-Llonch, Montserrat
    Dukes, Ellen
    Rousseau, Catherine
    [J]. CLINICAL THERAPEUTICS, 2006, 28 (11) : 1922 - 1934
  • [2] COST-EFFECTIVENESS ANALYSIS OF PREGABALIN IN THE TREATMENT OF DIABETIC PERIPHERAL NEUROPATHY
    Meshkini, Hashemi A.
    Keshavarz, K.
    Naser, Gharib Z.
    Nikfar, S.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A663 - A663
  • [3] Pregabalin in the treatment of neuropathic pain associated with diabetic peripheral neuropathy
    Frank, B.
    Cousins, M. J.
    [J]. FUTURE NEUROLOGY, 2008, 3 (06) : 631 - 639
  • [4] Pregabalin versus gabapentin in the management of peripheral neuropathic pain associated with post-herpetic neuralgia and diabetic neuropathy: a cost effectiveness analysis for the Greek healthcare setting
    Kostas Athanasakis
    Ioannis Petrakis
    Eleftheria Karampli
    Elli Vitsou
    Leonidas Lyras
    John Kyriopoulos
    [J]. BMC Neurology, 13
  • [5] Pregabalin versus gabapentin in the management of peripheral neuropathic pain associated with post-herpetic neuralgia and diabetic neuropathy: a cost effectiveness analysis for the Greek healthcare setting
    Athanasakis, Kostas
    Petrakis, Ioannis
    Karampli, Eleftheria
    Vitsou, Elli
    Lyras, Leonidas
    Kyriopoulos, John
    [J]. BMC PSYCHIATRY, 2013, 13
  • [6] COST-EFFECTIVENESS ANALYSIS OF PREGABALIN FOR THE TREATMENT OF NEUROPATHIC PAIN IN COLOMBIA
    Ordonez Molina, J. E.
    Orozco Giraldo, J. J.
    Gutierrez-Ardila, M., V
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A118 - A118
  • [7] COST-EFFECTIVENESS ANALYSIS OF PREGABALIN IN THE TREATMENT OF CENTRAL NEUROPATHIC PAIN
    Karbusicka, M.
    Kolek, M.
    Duba, J.
    Vothova, P.
    Kova, Dolec J.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A670 - A670
  • [8] Diabetic Peripheral Neuropathy and the Management of Diabetic Peripheral Neuropathic Pain
    Morales-Vidal, Sarkis
    Morgan, Christopher
    McCoyd, Mathew
    Hornik, Alejandro
    [J]. POSTGRADUATE MEDICINE, 2012, 124 (04) : 145 - 153
  • [9] The Effectiveness and Cost-effectiveness of Pregabalin in the Treatment of Diabetic Peripheral Neuropathy: A Systematic Review and Economic Model
    Meshkini, Amir Hashemi
    Keshavarz, Khosro
    Gharibnaseri, Zahra
    Nikfar, Shekoufeh
    Abdollahi, Mohammad
    [J]. INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2012, 8 (06) : 490 - 495
  • [10] COST-EFFECTIVENESS OF MIROGABALIN FOR THE TREATMENT OF DIABETIC PERIPHERAL NEUROPATHIC PAIN IN TAIWAN
    Gray, E.
    Ye, X.
    Fleishman, D.
    Wang, S. J.
    Wang, Y. F.
    [J]. VALUE IN HEALTH, 2019, 22 : S275 - S275
12345